Maintenance daily oral etoposide versus no further therapy following induction chemotherapy with etoposide plus ifosfamide plus cisplatin in extensive small-cell lung cancer: A Hoosier Oncology Group randomized study

Annals of Oncology

Volumn 13, Issue 1, 2002, Pages 95-102

  Hanna, N H ^a,b,f   Sandler, A B ^a   Loehrer Sr , P J ^a,b,c   Ansari, R ^b,d   Jung, S H ^e   Lane, K ^e   Einhorn, L H ^a,b,c  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^b Hoosier Oncology Group   (United States)

^c WALTHER CANCER INSTITUTE   (United States)

^d Michiana Hematology/Oncology   (United States)

^e INDIANA UNIVERSITY   (United States)

^f NONE   (United States)

Author keywords

Lung cancer; Maintenance; Small cell; VIP

Indexed keywords

CISPLATIN; ETOPOSIDE; IFOSFAMIDE; MESNA;

ADULT; AGED; ALOPECIA; ARTICLE; BLOOD TOXICITY; BONE MARROW; CANCER GROWTH; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; KIDNEY FUNCTION; LIVER TOXICITY; LUNG SMALL CELL CANCER; LUNG TOXICITY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; METASTASIS; NAUSEA; NEUROTOXICITY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STOMATITIS;

EID: 0036230962     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdf014     Document Type: Article

References (40)

1. Cancer Statistics, 2000
2. A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis
3. Overview of ifosfamide in small cell lung cancer
4. Cisplatin plus etoposide with and without ifosfamide in extensive small cell lung cancer: A Hoosier Oncology Group Study
5. Daily oral VP-16 in refractory germ cell tumors
6. Maintenance chemotherapy with daily oral etoposide following salvage therapy in patients with germ cell tumors
7. Bioavailability, pharmacokinetics and clinical effects of an oral preparation of etoposide
8. VP-16-213 monotherapy for remission induction of small cell lung cancer: A randomized trial using dosage schedule
9. A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer
10. Phase II trial of daily oral VP-16 in refractory small cell lung cancer: A Hoosier Oncology Group Study
11. Discrete sequential boundaries for clinical trials
12. Non-parametric estimation from incomplete observation
13. Regression models and life-tables
14. Small-cell carcinoma of the lung: Combined chemotherapy and radiation
15. Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent
16. Randomized study of cyclophosphamide, doxorubicin and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: A phase III trial of the Southeastern Cancer Study Group
17. Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: An intergroup study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group
18. Randomized phase III study of irinotecan (CPT-11) and cisplatin versus etoposide and cisplatin in extensive-disease small-cell lung cancer: Japan Clinical Oncology Group Study (JCO9511)
19. A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small-cell phase III study of the Eastern Cooperative Oncology Group
20. Maintenance chemotherapy in limited small cell lung cancer: A randomized controlled trial
21. Comparison of combination chemotherapy-radiation therapy versus cyclophophamide-radiation therapy effects of maintenance chemotherapy and prophylactic whole brain irradiation
22. Maintenance chemotherapy for anaplastic small cell carcinoma of the bronchi: A randomized, controlled trial
23. Cisplatin plus etoposide consolidation following cyclophosphamide, doxorubicin, and vincristine in limited small-cell lung cancer
24. Combination chemotherapy with or without thoracic radiotherapy in limited-stage small-cell lung cancer: A randomized trial of the Southeastern Cancer Study Group
25. Six vs. twelve cycles for complete responders to chemotherapy in small cell lung cancer: Definitive results of a randomized clinical trial
26. Maintenance chemotherapy in small-cell lung cancer: Long term results of a randomized trial
27. Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer
28. Controlled trial of twelve versus six courses of chemotherapy in the treatment of small-cell lung cancer
29. Duration of chemotherapy in small cell lung cancer: A Cancer Research Campaign trial
30. A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide factors. Medical Research Council Lung Cancer Working Party
31. Long term follow-up of a randomised trial of combined chemoradiotherapy induction treatment, with and without maintenance chemotherapy in patients with small cell carcinoma of the lung
32. Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593-a phase III trial of the Eastern Cooperative Oncology Group
33. Long-term results in combined-modality treatment of small cell carcinoma of the lung
34. Induction chemo-radiotherapy and maintenance alternating chemotherapy for small cell lung cancer
35. Chemotherapy induction, consolidation radiotherapy and maintenance alternating chemotherapy in small cell carcinoma of the lung
36. Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer
37. Induction chemotherapy with ifosfamide, etoposide, and anthracycline for small cell lung cancer: Experience of the European Lung Cancer Working Party
38. Combined-modality treatment of small-cell lung cancer: Randomized comparison of three induction chemotherapies followed by maintenance chemotherapy with or without radiotherapy to the chest
39. A randomized clinical trial in bronchogenic small-cell carcinoma evaluating alternating maintenance therapy of vincristine, adriamycin, procarbazine, and etoposide (VAPE) with cyclophosphamide, CCNU, and CCM maintenance alone in complete responders following VAPE induction and late intensification
40. Maintenance chemotherapy for small cell lung cancer: A critical review of the literature